| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Departments of Anaesthesiaand Health Care and
Epidemiology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
Address correspondence to:Dr. Himat Vaghadia, Department of Anesthesia (LSP2449), Vancouver Hospital and Health Science Centre, 910 West 10th Avenue, Vancouver, B.C. V5Z 4E3 Canada. Phone: 604-875-4304; Fax: 604-875-5209; E-mail: hvaghadi{at}vanhosp.bc.ca
| Abstract |
|---|
|
|
|---|
Methods: 144 ASA I - II ambulatory patients for dental extraction under anesthesia were studied. Subjects received either 3mg d-tubocurarine (Group II) or saline (Groups I, III) iv prior to induction of anesthesia with 20 µgkg1 alfentanil and 2.5 mgkg1 propofol followed by 1.5 mgkg1 succinylcholine (II and III) or saline 0.9% (I) for muscle relaxation. The ease of airway management and the postoperative incidence, severity and distribution of muscle pains were examined.
Results: Intubation was successful in all patients and there were no differences in jaw mobility, ease of bag-mask ventilation, visualization of the vocal cords or cord position. Limb movement was more common during intubation in Group I (37.5%) than in Group III (8.3%) or Group II (2%), P < 0.05. At home, VAS scores for myalgia were higher in Group III than in Group I and II. Neck myalgia was more common in Group III (72%) than in Groups II (44%) and I (41%), P < 0.05. Myalgias were also more common in Group III patients (P < 0.05).
Conclusion: Acceptable intubating conditions were achieved with propofol and alfentanil alone. Succinylcholine reduced limb movement during intubation but was associated with postoperative myalgias for up to five days. Precurarisation with tubocurarine reduced the severity of succinylcholine myalgia.
| Introduction |
|---|
|
|
|---|
We therefore, studied intubating conditions and the incidence and distribution of myalgias in patients intubated with propofol / alfentanil compared to propofol / alfentanil/ succinylcholine (sux) with and without precurarisation.
| Methods |
|---|
|
|
|---|
|
Group II (dTc- succ): Subjects received 3mg d-tubocurarine for precurarisation and 1.5 mgkg1 for intubation.
Group III (saline-sux): Subjects received saline for precurarisation and 1.5 mgkg1 succinylcholine for intubation.
One minute after administration of relaxant or saline, the ease of mask ventilation (easy or difficult), jaw mobility (mobile or partly mobile), vocal cord visualization at laryngoscopy (full, partial or no exposure), position of the cords at intubation (open, mid-open or closed), and movement of patients on intubation (yes or no) were recorded (Table III
) simultaneously with intubation. The patients were then intubated nasally by direct laryngoscopy blind nasal intubation was not performed in any patient. Anesthesia was maintained with O2 40% in N2O and varying concentrations of isoflurane. Breathing was assisted until spontaneous ventilation returned. Anesthesia was administered by one anesthesiologist (J.P.) who remained blind to the group assignments. All drugs were prepared by a staff anesthesiologist not involved with the study to keep the study investigator blinded. Study drugs were prepared in identical syringes and in identical volumes. In the post anaesthetic room (PAR), the patients were asked by the same blinded anesthesiologist to indicate their degree of muscle pain using the visual analogue scale (VAS) anchored at 0 (no myalgia) and 10 (maximum myalgia) and, if present, to show diagramatically the location of their pain. All VAS assessments were performed when the patients were alert and oriented. All patients were followed for five days after surgery and asked to score their degree of muscle pain (VAS) at 24, 48 and 72 hr postoperatively. The postoperative questionnaire was returned by mail to the investigator.
|
of 0.05 and a ß of 0.2 it was estimated that a minimum number of 40 patients per group would be required to show a difference of 25% in the incidence of myalgia (control = 70%). | Results |
|---|
|
|
|---|
|
At home, there were differences in the severity of myalgia (VAS score) among groups on days one to four but not on day five. Group III patients had significantly higher median VAS myalgia scores than Group II on days one to four and Group I on days one and two. (Table IV
). The incidence of myalgias at home by muscle group is summarized in the Figure
. There was a higher incidence of neck myalgia in Group III (72%) compared with Group II (44%) and Group I (41%), P < 0.05. There was a higher incidence of chest myalgia in Group III (21%) compared to Group II (2.6%) and Group I (5%), P < 0.01. There was a higher incidence of upper back myalgia in Group III (30%) than in Group I (7.7%), P = 0.01. Abdominal myalgias were more common in Group III (23%) than in Group II (2.6%), P =0.006. The occurrence of upper and lower limb myalgia did not differ among groups.
|
|
| Discussion |
|---|
|
|
|---|
Intubation of the trachea without the use of neuromuscular blockade has been well studied (Table V
).1,2,47 Propofol alone or in combinations with small (< 40 µgkg1) doses of alfentanil was more likely to be associated with suboptimal intubating conditions.1,47 Similarly, propofol in conjunction with < 3 µgkg1 of remifentanil was associated with suboptimal intubating conditions.2 However, these studies employed multiple anesthesiologists for intubation. In the present study we controlled for inter-observer variability by employing one blinded anesthesiologist for airway assessment and intubation. We found suboptimal intubating conditions in 37.5% of patients in Group 1 (propofol/alfentanil alone) due to limb movement. However, unlike previous studies all patients in all three groups were successfully intubated. The principal reasons for suboptimal intubating conditions when employing propofol/ alfentanil without muscle relaxants for intubation are limb movement, coughing and poor view. In the present study, we did not observe coughing during intubation. This is an important consideration because coughing may predispose to an increased incidence of postoperative sore throat. The present study was not designed to evaluate the problem of postoperative sore throat - future studies need to address this issue. The use of alfentanil in doses > 20 µgkg1 appears to overcome movement during intubation.1,47 The adjunctive administration of lidocaine 1 mgkg1 appears to reduce coughing during intubation.5 Poor visibility during laryngoscopy can be subjective and is dependent on the experience of the anesthesiologist. However, additional administration of muscle relaxants improves visibility and success rate but comes at a price - myalgia.7
|
The incidence of postoperative myalgia in outpatients varies from 1.5 to 89% as reported in earlier studies.10 Myalgias appears to occur even if succinylcholine is replaced with non-depolarizing muscle relaxants.810 Myalgias can be very debilitating and 50% and 23% of outpatients receiving succinylcholine and atracurium respectively had to stay in bed or take analgesics to obtain relief.10 The variable incidence of myalgias in different studies appears to be a function of type of surgical population studied, duration of follow up and type of follow up. Our study provides comprehensive follow up data of outpatients that allows meaningful conclusions to be drawn with respect to avoiding muscle relaxants in outpatient and substituting them with short acting opioids. We have demonstrated that when succinylcholine is avoided in a propofol/alfentanil induction-intubation technique, there is a beneficial effect in terms of a lower incidence and severity of postoperative myalgia. One limiting factor in our study was that we did not include a study group in which a non-depolarizing muscle relaxant was substituted for succinylcholine. However, this would not be reflective of the practice in our daycare unit and we did not have strong evidence from previous studies to include such a group.
With respect to the 6% incidence of closed cords in Group I, it could be argued that even though there was no difference in intubating conditions among the three groups, our study did not have sufficient power to detect a difference. Unfortunately, it would require a sample size of at least 250 patients per group to show a decrease in incidence of closed cords to 4% in the treatment group with sufficient power. Such a large sample size is too prohibitive to make it worth performing a study that may reduce the low incidence of closed cords to an even lower level with succinylcholine. From an ethical perspective it would also be questioned because the risk of myalgia would be considerable as already shown.
In conclusion, the use of propofol / alfentanil for intubation was found to be associated with satisfactory and successful intubation although a significant number of patients exhibited some limb movement during intubation. This technique was also associated with a lower incidence and severity of postoperative myalgia for two days. Succinylcholine administration abolished limb movement during intubation. The 6% incidence of closed cords in the propofol/ alfentanil group was also avoided with the use of succinylcholine. These benefits of succinylcholine were associated with significant increase in postoperative myalgias. Precurarisation with tubocurarine was also beneficial in reducing succinylcholine-induced myalgia. Patients who received d-tubocurarine had no more myalgias than those who did not have succinylcholine. Therefore, while intubation can be performed without muscle relaxants, the choice of precurarisation and subsequent succinylcholine produce optimal intubating conditions and minimal myalgia. It is suggested that the decision to avoid muscle relaxants for intubation should be based upon the experience of the anesthesiologist and that a muscle relaxant of choice should be readily available in case laryngoscopy is found to be suboptimal. Future areas to study include the use of inhalational agents to deepen anesthesia prior to intubation without muscle relaxants, the issue of sore throat, and the potential role for future ultra short acting non depolarizing muscle relaxants.
Accepted for publication January 20, 2000.
| References |
|---|
|
|
|---|
2 Stevens JB, Wheatley L. Tracheal intubation in ambulatory surgery patients: using remifentanil and propofol without muscle relaxants. Anesth Analg 1998; 86: 459.[Abstract]
3 Mallampatti SR, Gatt SP, Gugino LD, et al. A clinical sign to predict difficult tracheal intubation: a prospective study. Can Anesth Soc J 1985; 32: 42934.[Medline]
4
McConaghy P, Bunting HE. Assessment of intubating conditions in children after induction with propofol and varying doses of alfentanil. Br J Anaesth 1994; 73: 5969.
5
Davidson JAH, Gillespie JA. Tracheal intubation after induction of anaesthesia with propofol, alfentanil and i.v. lignocaine. Br J Anaesth 1993; 70: 1636.
6
Coughlan SFE, McDonald PF, Csepregi G. Use of alfentanil with propofol for nasotracheal intubation without neuromuscular block. Br J Anaesth 1993; 70: 8991.
7
Alcock R, Peachey T, Lynch M, McEwan T. Comparison of alfentanil with suxamethonium in facilitating nasotracheal intubation in day case anaesthesia. Br J Anaesth 1993; 70: 347.
8 Smith I, Ding Y, White PF. Muscle pain after outpatient laparoscopy - influence of propofol versus thiopental and enflurane. Anesth Analg 1993; 76: 11814.[Medline]
9 Zahl K, Apfelbaum JL. Muscle pain occurs after outpatient laparoscopy despite the substitution of vecuronium for succinylcholine. Anesthesiology 1989; 70: 40811.[Medline]
10
Trepanier CA, Brousseau C, Lacerte L. Myalgia in outpatient surgery: comparison of atracurium and succinylcholine. Can J Anaesth 1988; 35: 2559.
This article has been cited by other articles:
![]() |
A. W. Woods and S. Allam Tracheal intubation without the use of neuromuscular blocking agents Br. J. Anaesth., February 1, 2005; 94(2): 150 - 158. [Full Text] [PDF] |
||||
![]() |
G. Kovacs, J. A. Law, J. Ross, J. Tallon, K. MacQuarrie, D. Petrie, S. Campbell, and C. Soder Acute airway management in the emergency department by non-anesthesiologists: [L'assistance respiratoire immediate realisee a l'urgence par des non-anesthesiologistes] Can J Anesth, February 1, 2004; 51(2): 174 - 180. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |